Vertice Pharma Promotes New CEO

Vertice Pharma has announced changes to its top executive role. Don DeGolyer, the company’s Founder, will join the Board of Directors and step down from his role as Chief Executive Officer. Simultaneously, Scott Meyers has been promoted to Chief Executive Officer, succeeding Don as the company’s leader. Scott previously served as the company’s Chief Operating Officer.

Vertice Pharma develops, manufactures, markets, and distributes high-quality and affordable pharmaceutical products through its operating companies. Vertice Pharma has global headquarters in the United Kingdom and United States, and is headquartered in New Providence, New Jersey.